Literature DB >> 3133132

Prostacyclin biosynthesis and phospholipase activity in hypoxic rat myocardium.

H Kawaguchi1, H Yasuda.   

Abstract

Phospholipid metabolism was studied in rat myocardial slices that were incubated under normoxia or hypoxia for up to 24 hours. Phospholipid degradation was prominent in hypoxic myocardium, particularly phosphatidylcholine, which markedly decreased after 24 hours of hypoxia. In contrast, lysophosphatidylcholine increased. The mechanism of phospholipid degradation in hypoxic myocardium was studied. The highest activity for phospholipase A2 among subcellular fractions was found in microsomal fraction. In hypoxic myocardium, this phospholipase A2 activity markedly increased and had substrate specificity toward phosphatidylcholine and phosphatidylethanolamine. Phosphatidylcholine was slightly hydrolyzed in control myocardium, but it was markedly hydrolyzed in hypoxic myocardium. Phospholipase C activity was found in cytosol and had a high substrate specificity toward phosphatidylinositol. In hypoxic myocardium, its activity gradually decreased during hypoxic incubation. Prostacyclin biosynthesis was also determined. The synthesis of prostacyclin in hypoxic myocardial microsomes did not increase. These results suggest that hypoxia causes phospholipid degradation and activates phospholipase A2 activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133132     DOI: 10.1161/01.res.62.6.1175

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  Lysophosphatidylcholine-induced mitochondrial fission contributes to collagen production in human cardiac fibroblasts.

Authors:  Hui-Ching Tseng; Chih-Chung Lin; Li-Der Hsiao; Chuen-Mao Yang
Journal:  J Lipid Res       Date:  2019-07-30       Impact factor: 5.922

2.  Changes in phosphoinositide-specific phospholipase C and phospholipase A2 activity in ischemic and reperfused rat heart.

Authors:  D W Schwertz; J Halverson
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

3.  The leakage of fatty acid binding protein from cultured myocardial cells during hypoxia.

Authors:  H Takahashi; H Kawaguchi; K Iizuka; H Yasuda
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

4.  Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes.

Authors:  S C Armstrong; C E Ganote
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

5.  Characterization of cytoplasmic and membrane-associated phosphatidylinositol 4,5-biphosphate phospholipase C activities in guinea pig ventricles.

Authors:  I Edes; E G Kranias
Journal:  Basic Res Cardiol       Date:  1990 Jan-Feb       Impact factor: 17.165

6.  Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion.

Authors:  H Nakamura; R A Nemenoff; J H Gronich; J V Bonventre
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

7.  Effect of palmitic acid and fatty acid binding protein on ventricular fibrillation threshold in the perfused rat heart.

Authors:  M Makiguchi; H Kawaguchi; M Tamura; H Yasuda
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

8.  Increased calcium release from sarcoplasmic reticulum stimulated by inositol trisphosphate in spontaneously hypertensive rat heart cells.

Authors:  H Kawaguchi; H Sano; H Okada; K Iizuka; H Okamoto; T Kudo; T Murakami; A Kitabatake
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

9.  [Decreasing sarcoplasmic reticular calcium gives rise to myocardial protection--the effect of thapsigargin for myocardial protection under conditions of normothermia].

Authors:  Y Kumada; F Yamamoto; H Yamamoto; T Ishikawa; K Kagisaki; H Hirose
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-04

10.  Prostaglandin expression profile in hypoxic osteoblastic cells.

Authors:  Christina M Lee; Damian C Genetos; Alice Wong; Clare E Yellowley
Journal:  J Bone Miner Metab       Date:  2009-05-28       Impact factor: 2.626

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.